Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)

India flag India · Delayed Price · Currency is INR
114.66
+2.06 (1.83%)
May 12, 2026, 3:30 PM IST
Market Cap2.38B +71.5%
Revenue (ttm)516.17M +5.5%
Net Income6.52M +27.6%
EPS0.32 +31.7%
Shares Out20.80M
PE Ratio365.55
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,250
Average Volume16,940
Open112.00
Previous Close112.60
Day's Range110.30 - 115.00
52-Week Range67.72 - 147.00
Beta0.66
RSI47.14
Earnings DateMay 26, 2026

About NSE:LOTUSEYE

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery t... [Read more]

Sector Healthcare
Founded 1989
Employees 348
Stock Exchange National Stock Exchange of India
Ticker Symbol LOTUSEYE
Full Company Profile

Financial Performance

In fiscal year 2025, NSE:LOTUSEYE's revenue was 495.63 million, an increase of 2.81% compared to the previous year's 482.10 million. Earnings were 7.39 million, a decrease of -74.63%.

Financial Statements